Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST)

Clinical Cardiology

Volumn 36, Issue 8, 2013, Pages 442-447

  Winchester, David E ^a   Cooper Dehoff, Rhonda M ^a,b   Gong, Yan ^b   Handberg, Eileen M ^a   Pepine, Carl J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; TRANDOLAPRIL; VERAPAMIL;

AGE DISTRIBUTION; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GERIATRIC DISORDER; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; SMOKING; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

AGE FACTORS; AGED; ANGINA PECTORIS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPERTENSION; INDOLES; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VERAPAMIL;

EID: 84882278618     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22145     Document Type: Article

References (36)

1. Bavry AA, Anderson RD, Gong Y, et al. Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the International Verapamil-SR/Trandolapril Study. Hypertension. 2010; 55: 48-53.
2. Poole-Wilson PA, Lubsen J, Kirwan BA, et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet. 2004; 364: 849-857.
3. Carpiuc KT, Wingard DL, Kritz-Silverstein D, et al. The association of angina pectoris with heart disease mortality among men and women by diabetes status: the Rancho Bernardo Study. J Womens Health (Larchmt). 2010; 19: 1433-1439.
4. Hemingway H, McCallum A, Shipley M, et al. Incidence and prognostic implications of stable angina pectoris among women and men. JAMA. 2006; 295: 1404-1411.
5. Kannel WB, Feinleib M,. Natural history of angina pectoris in the Framingham study: prognosis and survival. Am J Cardiol. 1972; 29: 154-163.
6. Murphy NF, Stewart S, Hart CL, et al. A population study of the long-term consequences of Rose angina: 20-year follow-up of the Renfrew-Paisley study. Heart. 2006; 92: 1739-1746.
7. Rosengren A, Wilhelmsen L, Hagman M, et al. Natural history of myocardial infarction and angina pectoris in a general population sample of middle-aged men: a 16-year follow-up of the Primary Prevention Study, Goteborg, Sweden. J Intern Med. 1998; 244: 495-505.
8. Buckley B, Murphy AW,. Do patients with angina alone have a more benign prognosis than patients with a history of acute myocardial infarction, revascularisation or both? Findings from a community cohort study. Heart. 2009; 95: 461-467.
9. Hjemdahl P, Eriksson SV, Held C, et al. Favourable long term prognosis in stable angina pectoris: an extended follow-up of the angina prognosis study in Stockholm (APSIS). Heart. 2006; 92: 177-182.
10. Sigurdsson E, Thorgeirsson G, Sigvaldason H, et al. Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study. Ann Intern Med. 1995; 122: 96-102.
11. Rosendorff C, Black HR, Cannon CP, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007; 115: 2761-2788.
12. Pepine CJ, Handberg EM, Cooper-DeHoff RM, et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA. 2003; 290: 2805-2816.
13. Gong Y, Handberg EM, Gerhard T, et al. Systolic blood pressure and subjective well-being in patients with coronary artery disease. Clin Cardiol. 2009; 32: 627-632.
14. Cooper-DeHoff RM, Gong Y, Handberg EM, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010; 304: 61-68.
15. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 1903-1913.
16. Clayton TC, Lubsen J, Pocock SJ, et al. Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients. BMJ. 2005; 331: 869.
17. Daly CA, De Stavola B, Sendon JL, et al. Predicting prognosis in stable angina-results from the Euro heart survey of stable angina: prospective observational study. BMJ. 2006; 332: 262-267.
18. Tenenbaum A, Fisman EZ, Boyko V, et al. Prevalence and prognostic significance of unrecognized systemic hypertension in patients with diabetes mellitus and healed myocardial infarction and/or stable angina pectoris. Am J Cardiol. 1999; 84: 294-298.
19. Messerli FH, Mancia G, Conti CR, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006; 144: 884-893.
20. Heron M, Hoyert DL, Murphy SL, et al. Deaths: final data for 2006. Natl Vital Stat Rep. 2009; 57: 1-134.
21. Pepine CJ, Kerensky RA, Lambert CR, et al. Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol. 2006; 47: S30-S35.
22. Bugiardini R, Bairey Merz CN,. Angina with "normal" coronary arteries: a changing philosophy. JAMA. 2005; 293: 477-484.
23. Anderson RD, Pepine CJ,. How to manage angina with normal coronary arteries (update). In: Fauci AS, Braunwald E, Kasper DL, et al, eds. Harrison's Principles of Internal Medicine. New York, NY: McGraw-Hill; 2010. http://www.accessmedicine.com/updatesContent.aspx?aid=1001522.
24. Lerner DJ, Kannel WB,. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986; 111: 383-390.
25. Jennings RB, Murry CE, Steenbergen C Jr, et al. Development of cell injury in sustained acute ischemia. Circulation. 1990; 82: II2-II12.
26. Kloner RA, Jennings RB,. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. Circulation. 2001; 104: 3158-3167.
27. Evrengul H, Celek T, Tanriverdi H, et al. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy. Can J Cardiol. 2005; 21: 915-920.
28. Mladenovic ZT, Angelkov-Ristic A, Tavciovski D, et al. The cardioprotective role of preinfarction angina as shown in outcomes of patients after first myocardial infarction. Tex Heart Inst J. 2008; 35: 413-418.
29. Ottani F, Galli M, Zerboni S, et al. Prodromal angina limits infarct size in the setting of acute anterior myocardial infarction treated with primary percutaneous intervention. J Am Coll Cardiol. 2005; 45: 1545-1547.
30. Solomon SD, Anavekar NS, Greaves S, et al. Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling. J Am Coll Cardiol. 2004; 43: 1511-1514.
31. Gehi AK, Ali S, Na B, et al. Inducible ischemia and the risk of recurrent cardiovascular events in outpatients with stable coronary heart disease: the heart and soul study. Arch Intern Med. 2008; 168: 1423-1428.
32. Brorsson B, Bernstein SJ, Brook RH, et al. Quality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal population. Heart. 2002; 87: 140-145.
33. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356: 1503-1516.
34. Buckley BS, Simpson CR, McLernon DJ, et al. Five year prognosis in patients with angina identified in primary care: incident cohort study. BMJ. 2009; 339: b3058.
35. LaCroix AZ, Guralnik JM, Curb JD, et al. Chest pain and coronary heart disease mortality among older men and women in three communities. Circulation. 1990; 81: 437-446.
36. Dagenais GR, Lu J, Faxon DP, et al. Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial. J Am Coll Cardiol. 2013; 61: 702-711.